Walter de Gruyter GmbH & Co. KG Company Profile

06:58 EST 11th December 2018 | BioPortfolio



Genthiner Strasse 13


Phone: 49 30 260 05-0
Fax: 49 30 260 05-251

News Articles [232 Associated News Articles listed on BioPortfolio]

Peerwith partners with academic publisher, De Gruyter to develop collaborative peer-2-peer marketplace for authors

Amsterdam, Netherlands, 10th September 2018 / Sciad Newswire / Peerwith is pleased to announce a new partnership with the independent academic publisher, De Gruyter, a company with a tradition dati...

De Gruyter partners with Code Ocean to improve research reproducibility

(Code Ocean) De Gruyter, publisher of more than 700 journals in the humanities, social sciences, law and STM and Code Ocean, a computational reproducibility platform, announce a partnership that enabl...

Walter A. Twachtman, Jr. is recognized by Continental Who's Who

GLASTONBURY, Conn., June 29, 2018/PRNewswire/ -- Walter A. Twachtman, recognized by Continental Who's Who as a Lifetime Member in the field Read more...

Apple: Beispiel von Netflix und Amazon macht Schule!

New York ( - Apple-Aktienanalyse von Analyst Walter Piecyk von BTIG: Walter Piecyk, Aktienanalyst von BTIG, bekräftigt im Rahmen einer Aktienanalyse seine Kaufempfehlung für die ....

Surprise finding uncovers balancing act between birth defects and cancer

(Walter and Eliza Hall Institute) Walter and Eliza Hall Institute researchers have made a surprise discovery about how subtle changes in the way cell survival is regulated during embryonic development...

New financing round at oncgnostics GmbH close

The life sciences company oncgnostics GmbH was able to double its investment of 750,000 euros following the very rapid and successful completion of its second crowd investing campaign on Seedmatch. A...

Imaging collaboration sheds new light on cancer growth

(Walter and Eliza Hall Institute) Walter and Eliza Hall Institute researchers have uncovered new insights into how the normal controls on cell growth are lost in cancer cells, leading to rapid tumour ...

High on the highway -- stoned-driving on the increase

(De Gruyter) Getting behind the wheel after cannabis use is on the rise in the US, and THC, not alcohol, is now the most commonly detected intoxicant in US drivers. Detecting levels of THC, however, i...

Clinical Trials [60 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Mild Water-Filtered Near Infrared Whole-Body-Hyperthermia as an Adjunct in the Treatment of Fibromyalgia

The purpose of the study is to evaluate whether mild walter-filtered near infrared hyperthermia produces an additional benefit when applied as an adjunct to standard multimodal rehabilitat...

User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015

The user performance evaluation shows whether people with diabetes are able to obtain accurate measurement results with a blood glucose monitoring system. In this study, user performance e...

Companies [547 Associated Companies listed on BioPortfolio]

Walter de Gruyter GmbH & Co. KG


Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

Walter Reed Army Medical Center

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...


The Clinical Trials Center (CTC) was established as a clinical research unit in early 1992 within the Walter Reed Army Institute of Research (WRAIR). Clinical researchers within the Institute needed t...

More Information about "Walter de Gruyter GmbH & Co. KG" on BioPortfolio

We have published hundreds of Walter de Gruyter GmbH & Co. KG news stories on BioPortfolio along with dozens of Walter de Gruyter GmbH & Co. KG Clinical Trials and PubMed Articles about Walter de Gruyter GmbH & Co. KG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Walter de Gruyter GmbH & Co. KG Companies in our database. You can also find out about relevant Walter de Gruyter GmbH & Co. KG Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record